| | | | |
CUSIP No. 90089L108 | | | | Page 7 of 8 Pages |
Explanatory Note: This Amendment No.2 (“Amendment No. 2”) amends and supplements the statement on Schedule 13D originally filed by the Reporting Persons on November 15, 2022 and as amended by amendment No. 1 on Schedule 13D filed by the Reporting Persons on January 17, 2024 (the “Schedule 13D”). Unless otherwise indicated, each capitalized term used but not defined in this Amendment No. 2 shall have the meaning assigned to such term in the Schedule 13D.
Item 4. | Purpose of Transaction |
Item 4 of Schedule 13D is hereby amended and supplemented to add the following before the last paragraph:
On April 3, 2024, Mo Chen, as Executive Chairman of the Company’s Board of Directors (the “Board”), entered into an amended and restated cooperation agreement (the “Amended Cooperation Agreement”) with the Company, which amended and restated the cooperation agreement dated January 16, 2024 by and between Mo Chen with the Company.
Pursuant to the Amended Cooperation Agreement, in addition to the terms and conditions agreed to between Mo Chen and the Company in the Cooperation Agreement, Mo Chen agreed that during a period of two years from January 16, 2024, the effective date of the Cooperation Agreement, he will not (i) solicit, initiate, discuss, negotiate, enter into or effectuate, directly or indirectly, any related party transaction between the Company or any of its subsidiaries and Hydron, Inc. or any of its subsidiaries, or (ii) cause any funds of the Company or any of its subsidiaries to be used for or to advance the business of Hydron, Inc. or its subsidiaries.
The foregoing description of the Amended Cooperation Agreement is qualified in its entirety by reference to the Amended Cooperation Agreement, a copy of which is attached to this Schedule 13D as Exhibit 99.5 and incorporated herein by reference.
Item 6. | Contracts, Arrangements, Understandings or Relationships with respect to Securities of the Issuer |
Item 6 of Schedule 13D is hereby amended and supplemented as follows:
The information set forth in Item 4 of this Amendment is incorporated herein by reference.
Item 7. | Material to be Filed as Exhibits |
Item 7 of Schedule 13D is hereby amended and supplemented to add the following:
Exhibit 99.5 Amended and Restated Cooperation Agreement by and between the Company and Mo Chen dated April 3, 2024.
7